Home
TERN
TERN News

Latest Terns Pharmaceuticals Inc. (TERN) News on May 14, 2025

Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030?

Insider Monkey

5 days ago

Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030?

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

6 days ago

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

12 days ago

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

GlobeNewswire

14 days ago

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate

Simply Wall St.

21 days ago

We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate

Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround

Zacks

a month ago

Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)

Zacks

a month ago

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a month ago

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy

Zacks

2 months ago

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

GlobeNewswire

2 months ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Motley Fool

2 months ago

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

MT Newswires

3 months ago

William Blair Initiates Terns Pharmaceuticals at Market Perform

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

3 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

GlobeNewswire

3 months ago

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

MT Newswires

3 months ago

Terns Pharmaceuticals Names Andrew Gengos as Chief Financial Officer

Its CEO died. The company scrapped a promising program. Now, for their 2nd act.

Pharma Voice

3 months ago

Its CEO died. The company scrapped a promising program. Now, for their 2nd act.

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

GlobeNewswire

3 months ago

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

GlobeNewswire

3 months ago

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

3 months ago

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

3 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

4 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey

5 months ago

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock

Simply Wall St.

5 months ago

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock

MT Newswires

5 months ago

Oppenheimer Adjusts Price Target on Terns Pharmaceuticals to $20 From $17, Keeps Outperform Rating

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

GlobeNewswire

5 months ago

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

5 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

GlobeNewswire

6 months ago

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth

Simply Wall St.

6 months ago

We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire

6 months ago

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

GlobeNewswire

6 months ago

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

MT Newswires

6 months ago

Oppenheimer Initiates Terns Pharmaceuticals at Outperform With $17 Price Target

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

7 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

MT Newswires

7 months ago

Mizuho Raises Price Target on Terns Pharmaceuticals to $14 From $10, Keeps Outperform Rating

Insiders Snap Up These 2 ‘Strong Buy’ Stocks

TipRanks

8 months ago

Insiders Snap Up These 2 ‘Strong Buy’ Stocks

This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments

Motley Fool

8 months ago

This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments

GuruFocus.com

8 months ago

OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc

With 55% ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) boasts of strong institutional backing

Simply Wall St.

8 months ago

With 55% ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) boasts of strong institutional backing

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Motley Fool

8 months ago

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Should You Invest in This Under-the-Radar Weight Loss Stock?

Motley Fool

8 months ago

Should You Invest in This Under-the-Radar Weight Loss Stock?

1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More

Motley Fool

8 months ago

1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

8 months ago

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More

Zacks

8 months ago

Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More

MT Newswires

8 months ago

Terns Pharmaceuticals Prices $150.2 Million Public Offering

Terns Announces Pricing of Upsized $150.15 Million Public Offering

GlobeNewswire

8 months ago

Terns Announces Pricing of Upsized $150.15 Million Public Offering

Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug

Zacks

8 months ago

Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug

Terns Pharmaceuticals reports positive data from Phase I trial of obesity treatment

Clinical Trials Arena

8 months ago

Terns Pharmaceuticals reports positive data from Phase I trial of obesity treatment

MT Newswires

8 months ago

Terns Pharmaceuticals Launching Share Offering

Terns Announces Proposed Public Offering

GlobeNewswire

8 months ago

Terns Announces Proposed Public Offering

Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill

Barrons.com

8 months ago

Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill

Terns Pharmaceuticals' Oral GLP-1 Reaches Phase 1 Finish Line With Encouraging Weight Loss Data After One Month

Benzinga

8 months ago

Terns Pharmaceuticals' Oral GLP-1 Reaches Phase 1 Finish Line With Encouraging Weight Loss Data After One Month

MT Newswires

8 months ago

Terns Pharmaceuticals Says Obesity Drug Candidate Found Well Tolerated in Phase 1 Trial

Early study data puts Terns among obesity drug contenders

BioPharma Dive

8 months ago

Early study data puts Terns among obesity drug contenders

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

GlobeNewswire

8 months ago

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

Terns Surges 29.6% in Three Months: Will the Momentum Continue?

Zacks

8 months ago

Terns Surges 29.6% in Three Months: Will the Momentum Continue?

Wall Street Analysts Think Terns Pharmaceuticals (TERN) Could Surge 78.74%: Read This Before Placing a Bet

Zacks

9 months ago

Wall Street Analysts Think Terns Pharmaceuticals (TERN) Could Surge 78.74%: Read This Before Placing a Bet

Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire

9 months ago

Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

9 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

MT Newswires

9 months ago

Terns Pharmaceuticals Names Elona Kogan as Chief Legal Officer; CFO Mark Vignola to Leave in 'Planned Transition'

Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition

GlobeNewswire

9 months ago

Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition

Burger King Parent Company and More Stocks See Action From Activist Investors

Barrons.com

10 months ago

Burger King Parent Company and More Stocks See Action From Activist Investors

Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

Motley Fool

10 months ago

Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

GlobeNewswire

a year ago

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

GlobeNewswire

a year ago

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

GlobeNewswire

a year ago

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

GuruFocus.com

a year ago

Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals Announces Leadership Changes

GlobeNewswire

a year ago

Terns Pharmaceuticals Announces Leadership Changes

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

GlobeNewswire

a year ago

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

GlobeNewswire

a year ago

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

GlobeNewswire

a year ago

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

GlobeNewswire

a year ago

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

GlobeNewswire

a year ago

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

GlobeNewswire

a year ago

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Byline Bancorp Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

Byline Bancorp Full Year 2023 Earnings: EPS Beats Expectations

Eagle Bancorp, Inc. (NASDAQ:EGBN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Eagle Bancorp, Inc. (NASDAQ:EGBN) Q4 2023 Earnings Call Transcript

Best Growth Stocks to Buy for January 26th

Zacks

a year ago

Best Growth Stocks to Buy for January 26th

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

TriCo Bancshares Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

a year ago

TriCo Bancshares Full Year 2023 Earnings: EPS Misses Expectations

Triumph Financial, Inc. (NASDAQ:TFIN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Triumph Financial, Inc. (NASDAQ:TFIN) Q4 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Washington Trust: Q4 Earnings Snapshot

Washington Trust Reports Fourth Quarter and Full-Year 2023 Earnings

PR Newswire

a year ago

Washington Trust Reports Fourth Quarter and Full-Year 2023 Earnings

GuruFocus.com

a year ago

Triumph Financial Inc (TFIN) Reports Mixed Results Amidst Economic Headwinds

Farmers National Banc (FMNB) Tops Q4 Earnings and Revenue Estimates

Zacks

a year ago

Farmers National Banc (FMNB) Tops Q4 Earnings and Revenue Estimates

Share on Social Networks: